Fingerprint
Dive into the research topics where Maciej Pietrzak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A cardiac transcriptional enhancer is repurposed during regeneration to activate an anti-proliferative program
Rao, A., Russell, A., Segura-Bermudez, J., Franz, C., Dockery, R., Blatnik, A., Panten, J., Zevallos, M., McNulty, C., Pietrzak, M. & Goldman, J. A., Feb 2025, In: Development (Cambridge). 152, 4, dev204458.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
A Meta-Review of Spatial Transcriptomics Analysis Software
Gillespie, J., Pietrzak, M., Song, M. A. & Chung, D., Jul 2025, In: Cells. 14, 14, 1060.Research output: Contribution to journal › Review article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Chondrodystrophic Dogs as a Preclinical Large Animal Model of Discogenic Back Pain
Heimann, M. K., Tang, S. N., Gunsch, G., Kuchynsky, K., Klamer, B., Zhao, F., Co, M., Pietrzak, M., Richards, J., Klausner, J., Smith, A., Cimney, K., McBride-Gagyi, S., Youngblood, B., Corps, K., Askwith, C., Walter, B. A., Moore, S. A. & Purmessur, D., Sep 2025, In: JOR Spine. 8, 3, e70082.Research output: Contribution to journal › Article › peer-review
Open Access -
Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability
Sadee, W., Cheeseman, I. H., Papp, A., Pietrzak, M., Seweryn, M., Zhou, X., Lin, S., Williams, A. M., Wewers, M. D., Curry, H. M., Zhang, H., Cai, H., Kunsevi-Kilola, C., Tshivhula, H., Walzl, G., Restrepo, B. I., Kleynhans, L., Ronacher, K., Wang, Y. & Arnett, E. & 2 others, , Dec 2025, In: Communications biology. 8, 1, 950.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (Nature Medicine, (2022), 28, 10, (2155-2161), 10.1038/s41591-022-01962-5)
LCMC study investigators, Jan 2024, In: Nature Medicine. 30, 1, p. 303 1 p.Research output: Contribution to journal › Comment/debate
Open Access6 Link opens in a new tab Scopus citations